Click the icons below to search through Pioneer’s reports and documents.
- Are Drug Prices Driving Healthcare Cost Growth? (1235)
- Key Questions for Legislators on the Institute for Clinical and Economic Review (ICER) (637)
- Looming Challenges for ICER in Assessing the Value of Rare Disease Therapies (292)
- Transparency in Retail Drug Prices: Easy to Obtain but Accuracy May Be Doubtful (1172)
- Will New England See Lower Prices from Drug Pricing Transparency Legislation? (188)